Published in J Bacteriol on July 01, 1947
IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1965) 4.16
The measurement of the response of immunized mice to infection with Mycobacterium tuberculosis va. hominis. J Immunol (1957) 3.60
AN ACUTE PULMONARY GRANULOMATOUS RESPONSE IN MICE PRODUCED BY MYCOBACTERIAL CELLS AND ITS RELATION TO INCREASED RESISTANCE AND INCREASED SUSCEPTIBILITY TO EXPERIMENTAL TUBERCULOUS INFECTION. J Infect Dis (1964) 2.29
The immunizing activity against tuberculous infection in mice of enzymatically active particles isolated from extracts of Mycobacterium tuberculosis. J Bacteriol (1955) 2.13
The relation between the size of the infecting dose of tubercle bacilli and the survival time of mice. Am Rev Tuberc (1951) 2.03
NATURE OF THE LABILE IMMUNOGENIC SUBSTANCE IN THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1964) 1.94
FURTHER STUDIES ON A LABILE IMMUNOGENIC PARTICULATE SUBSTANCE ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1964) 1.72
The growth of recently isolated strains of Mycobacterium tuberculosis var. hominis in liquid media. J Bacteriol (1950) 1.67
Allergenicity of intracellular particles, cell walls, and cytoplasmic fluid from Mycobacterium tuberculosis. J Bacteriol (1960) 1.55
The difference in response of four strains of mice to immunization against tuberculous infection. Am Rev Respir Dis (1959) 1.53
EFFECT OF MITOCHONDRIAL STABILIZERS ON THE IMMUNOGENICITY OF THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol (1964) 1.46
Studies on the metabolism of Mycobacterium tuberculosis. I. The effect of carbohydrates and alcohols on the growth of Mycobacterium tuberculosis var. hominis. J Bacteriol (1953) 1.43
The oxidation of compounds related to the tricarboxylic acid cycle by whole cells and enzyme preparations of Mycobacterium tuberculosis var. hominis. J Bacteriol (1956) 1.27
Immunogenicity of particles isolated from Mycobacterium tuberculosis. Proc Soc Exp Biol Med (1957) 1.25
Studies on the metabolism of Mycobacterium tuberculosis. II. The effect of compounds related to the Kreb's tricarboxylic acid cycle on the growth of Mycobacterium tuberculosis var. hominis. J Bacteriol (1953) 1.20
Effect of homogenates of organs from immunized guinea pigs on the respiration of Mycobacterium tuberculosis. J Bacteriol (1960) 1.13
The effect of bovine plasma fractions on the growth of Mycobacterium tuberculosis var. hominis. J Bacteriol (1950) 1.11
The assessment of antituberculous chemotherapeutic activity in mice, using virulent human-type tubercle bacilli. Am Rev Tuberc (1951) 1.09
The effect of thiocarbanidin and related compounds on Mycobacterium tuberculosis var. hominis in vitro and in vivo. Am Rev Tuberc (1958) 1.03
Studies on the metabolism of Mycobacterium tuberculosis. IV. The effect of fatty acids on the growth of M. tuberculosis var. hominis. J Bacteriol (1954) 1.03
Effect of mycosuppressin on the respiration and growth of Mycobacterium tuberculosis. J Bacteriol (1962) 1.01
The significance of the response of mice to immunization with viable unclassified mycobacteria. Am Rev Respir Dis (1961) 1.00
Studies on the metabolism of Mycobacterium tuberculosis. III. The growth of Mycobacterium tuberculosis var. hominis in the presence of various intermediates of the dissimilation of glucose to pyruvic acid. J Bacteriol (1953) 0.99
Effect of mycosuppressin on the course of experimental tuberculosis in mice. J Bacteriol (1962) 0.98
Studies on the metabolism of Mycobacterium tuberculosis. V. The effect of amino acids on the growth of M. tuberculosis var. hominis. J Bacteriol (1954) 0.95
The relationship of sex to the susceptibility of normal and immunized mice to tuberculosis. Am Rev Respir Dis (1959) 0.91
Lysozyme treatment of tuberculous mice. J Infect Dis (1958) 0.90
The inactivation of isoniazid by filtrates and extracts of mycobacteria. Am Rev Tuberc (1955) 0.90
The effect of hormonal preparations on the survival of mice injected intravenously with virulent, attenuated, and avirulent Mycobacteria. Am Rev Tuberc (1954) 0.83
Response of mice to standard infecting doses of Mycobacterium tuberculosis var. hominis. Proc Soc Exp Biol Med (1955) 0.79
Elaiomycin, a new tuberculostatic antibiotic; biologic studies. Antibiot Chemother (Northfield) (1954) 0.76
The combined effect of streptomycin and para-aminosalicylic acid on experimental tuberculosis in mice. J Lancet (1947) 0.75
Tuberculostatic action of chloromycetin in vitro and in vivo. Proc Soc Exp Biol Med (1948) 0.75
The development in vitro of an avirulent, immunogenic variant of Mycobacterium tuberculosis var. hominis. Proc Soc Exp Biol Med (1956) 0.75
The effect of tween 80 in vitro on the bacteriostatic activity of 20 compounds for Mycobacterium tuberculosis. J Bacteriol (1948) 0.75
The production of "anti-isoniazid" substance of ioniazid-susceptible, isoniazid-resistant, and unclassified strains of mycobacteria. Am Rev Respir Dis (1960) 0.75
The effect of viomycin in vitro and in vivo on Mycobacterium tuberculosis. Am Rev Tuberc (1951) 0.75
The effect of the anti-isoniazid substance produced by mycobacteria on the chemotherapeutic activity of isoniazid in vivo. Am Rev Tuberc (1956) 0.75
The effect of bovine plasma on the tuberculostatic activity of gamma-pheroxypropylamine. Antibiot Chemother (Northfield) (1954) 0.75